Home › Research › Down syndrome and Alzheimer's
Preliminary investigation of obstructive sleep apnea and Alzheimer's disease in down syndrome
Yoon DM, Plante DT, Fleming V, Handen B, Lao P, Peven J, Christian B, Okonkwo O et al.. Sleep advances : a journal of the Sleep Research Society, 2025-07-23
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
This study provided a preliminary examination of indices of obstructive sleep apsnea (OSA) and sleep disruptions in adults with Down syndrome (DS), and their associations with Alzheimer's disease (AD) pathology and symptomatology. A total of 93 adults with DS (aged 25-61 years) from the Alzheimer Biomarker Consortium-DS completed cognitive assessments, MRI and positron emission tomography (PET) scans (assessing amyloid-beta [Aβ] and tau), and a one-night home sleep study using the WatchPAT-300 device. Study partners also reported on depressive symptoms and diagnoses. Correlational analyses examined relationships between sleep variables, PET biomarkers, and AD symptomatology (cognitive functioning and depressive mood), controlling for sociodemographics. A total of 81 participants (87 per cent) completed valid WatchPAT data. Of these, 60 (74 per cent) screened positive for OSA, and an additional 11 had a prior OSA diagnosis and used CPAP during the test night. Nearly half (45 per cent) of those screening positive for OSA had no prior diagnosis, indicating under-detection. Among the 22 participants using OSA treatment, 50 per cent continued to show sleep-disordered breathing, suggesting suboptimal treatment effectiveness. Higher wake percentage and shorter total sleep time were associated with greater Aβ and tau burden. Cognitive performance was negatively associated with wake percentage, total sleep time, and oxygenation indices (minimum oxygen, desaturation, and time ≤ 88 per cent oxygen). Depressive symptoms were negatively related to total sleep time. These findings add preliminary evidence linking sleep disruption and OSA with AD-related pathology and symptomatology. Larger, longitudinal studies are needed to confirm these associations and evaluate whether improving sleep quality and treating OSA may help delay AD onset in this high-risk population.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 93 participants. In this preliminary study of 93 adults with Down syndrome, most screened positive for obstructive sleep apnea, many without a prior diagnosis, and greater wake percentage and shorter sleep time were associated with higher amyloid and tau burden. The authors describe this as preliminary evidence linking sleep disruption and sleep apnea with Alzheimer's-related pathology, and no treatment for Alzheimer's disease is tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yoon, D. M., Plante, D. T., Fleming, V., Handen, B., Lao, P., Peven, J., et al. (2025). Preliminary investigation of obstructive sleep apnea and Alzheimer's disease in down syndrome. Sleep advances : a journal of the Sleep Research Society. https://doi.org/10.1093/sleepadvances/zpaf044
Vancouver
Yoon DM, Plante DT, Fleming V, Handen B, Lao P, Peven J, et al. Preliminary investigation of obstructive sleep apnea and Alzheimer's disease in down syndrome. Sleep advances : a journal of the Sleep Research Society. 2025. doi:10.1093/sleepadvances/zpaf044. PMID: 40917568.
BibTeX
@article{yoon2025-40917568,
author = {Yoon, D. M. and Plante, D. T. and Fleming, V. and Handen, B. and Lao, P. and Peven, J. and Christian, B. and Okonkwo, O. and others},
title = {{Preliminary investigation of obstructive sleep apnea and Alzheimer's disease in down syndrome}},
journal = {Sleep advances : a journal of the Sleep Research Society},
year = {2025},
doi = {10.1093/sleepadvances/zpaf044},
pmid = {40917568},
url = {https://doi.org/10.1093/sleepadvances/zpaf044}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Higher wake percentage and shorter total sleep time were associated with greater Aβ and tau burden.
- Cognitive performance was negatively associated with wake percentage, total sleep time, and oxygenation indices (minimum oxygen, desaturation, and time ≤ 88 per cent oxygen).
- These findings add preliminary evidence linking sleep disruption and OSA with AD-related pathology and symptomatology.
Why it matters
In this preliminary study of 93 adults with Down syndrome, most screened positive for obstructive sleep apnea, many without a prior diagnosis, and greater wake percentage and shorter sleep time were associated with higher amyloid and tau burden. The authors describe this as preliminary evidence linking sleep disruption and sleep apnea with Alzheimer's-related pathology, and no treatment for Alzheimer's disease is tested.
Study details
- Study designlongitudinal study
- Participants93
- Evidence strengthModerate
How this study scored 47/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Sleep advances : a journal of the Sleep Research Society) |
| Journal's citation record | 0 / 4 | SLEEP Advances: journal h-index 22 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 93 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sigan L. Hartley: h-index 43 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Washington University in St. Louis: institution h-index 1,962 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40917568) |
| Free to read | 2 / 2 | Free to read |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1093/sleepadvances/zpaf044
- PubMed: 40917568
- Original source →
- Free full text: SLEEP Advances →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.